Recognizing that many companies will have “urgent liquidity needs” in the coming months as a result economic and market conditions related to the spread of COVID-19, on Monday the New...
The novel coronavirus (COVID-19) pandemic has had, and will continue to have, a significant impact on the global economy, businesses and individuals. This memorandum summarizes the ways i...
Today the Pre-Emption Group (“PEG”) announced its expectations with regard to issuers complying with the Pre-Emption Group Principles in light of the unparalleled economic situation c...
As legal and governance officers continue to field urgent questions over the fallout from the COVID-19 pandemic, we’ve added several more items to our memo summarizing our thinking on t...
The CARES Act provides for a $349 billion expansion of the existing Small Business Administration loan program for small businesses. However, the CARES Act does not appear to have overrid...
Many of our clients are taking a close look at their sources and uses of cash over the next several quarters and beyond in the face of a potentially prolonged period of market and busines...
Our UK Corporate Finance Update: Coronavirus (COVID-19) – Related Measures and Guidance published earlier this week provided a summary of the initial measures taken, and guidance issued...
As the COVID-19 crisis continues to unfold, questions are arising concerning whether and to what extent firms may have greater latitude to collaborate with competitors to address public h...
This memorandum highlights some annual general meeting (AGM) considerations for UK foreign private issuers (FPIs) with listings in the United States arising from coronavirus (COVID-19), i...
The coronavirus (COVID-19) emergency has led to the debt of many companies in private equity portfolios trading at a significant discount. As a result, an increasing number of private equ...